Thomas Zilli

Progression-free Survival Following Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Treatment-naive Recurrence: A Multi-institutional Analysis

Piet Ost, Barbara Alicja Jereczek‐Fossa, Nicholas van As et al. · European Urology · 2015 · 283 citations

Adaptive Radiotherapy, Urology, Surgical Oncology +6

Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) database

Sébastien Salas, Noémie Resseguier, Jean‐Yves Blay et al. · Annals of Oncology · 2017 · 167 citations · Full text

Risk Calculator, Surgical Oncology, Solitary Fibrous Tumor +8

Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2–cT3 rectal adenocarcinoma (OPERA): a phase 3, randomised controlled trial

Jean‐Pierre Gérard, N. Barbet, Renaud Schiappa et al. · ˜The œLancet. Gastroenterology & hepatology · 2023 · 156 citations

Radiation Medicine, Surgical Oncology, Neoadjuvant Chemoradiotherapy +9

Androgen deprivation and high-dose radiotherapy for oligometastatic prostate cancer patients with less than five regional and/or distant metastases

Ulrike Schick, S. Jorcano, Philippe Nouet et al. · Acta Oncologica · 2013 · 153 citations · Full text

Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy

Elise De Bleser, Barbara Alicja Jereczek‐Fossa, Thomas Zilli et al. · European Urology · 2019 · 137 citations

Surgical Oncology, Urology, Radiation Therapy +8